封面
市場調查報告書
商品編碼
1983193

腫瘤消融市場:按技術、治療方法、應用和地區分類

Tumor Ablation Market, By Technology, By Treatment, By Application, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

腫瘤消融市場預計在2026年達到17.557億美元,預計到2033年將達到37.411億美元。預計從2026年到2033年,其複合年成長率將達到11.5%。

分析範圍 分析詳情
基準年 2025 市場規模(2026 年) 17.557億美元
效能數據 2020-2024 預測期 2026-2033
預測期(2026-2032 年)複合年成長率 11.50% 預計金額(2033 年) 37.411億美元

這種新型癌症治療方法的有效性取決於兩個因素:腫瘤大小和探針的可及性。通常,對於直徑小於3公分且易於經皮治療的癌症,治療重點在於徹底根除惡性腫瘤。隨著癌症的生長,根除難度增加,因此早期治療至關重要。

市場動態

老年人口的持續成長加重了醫療保健系統的經濟負擔。根據美國國家人口與社會科學研究所預測,美國65歲及以上人口將從2018年的5,200萬增加到2060年的約9,500萬,翻倍。老年人口的成長將推動腫瘤消融治療設備市場需求的成長。

另一方面,對於在美國銷售的醫療設備,美國食品藥物管理局(FDA)下屬的醫療設備和放射健康中心負責管理生產、標籤、包裝和儲存的框架和標準。為了獲得批准或授權,每個組織都必須遵守該公共監管機構制定的詳細標準清單,並保存相關的完整文件。

本報告的主要特點

  • 本報告指出了各個細分市場的潛在商機,並描述了該市場中一系列有吸引力的投資提案。
  • 此外,它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
  • 本報告根據以下參數分析了全球腫瘤消融市場主要企業的概況:公司概況、產品系列、主要亮點、財務表現和策略。
  • 本節根據以下參數介紹全球腫瘤消融市場的主要企業:公司概況、產品系列、主要亮點、財務表現和策略。
  • 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
  • 《全球腫瘤消融市場》報告面向該行業的各種相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過分析全球腫瘤消融市場中使用的各種策略矩陣來促進決策。

目錄

第1章:分析目標與假設

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 癌症發生率增加
    • 腫瘤消融治療相關的併發症
    • 人們對使用傳統治療方法進行消融手術的認知不斷提高
  • 影響分析
  • 主要亮點
  • 法規環境
  • 產品上市及核准
  • PEST分析
  • 波特五力分析
  • 企業合併趨勢

第4章 全球腫瘤消融市場:依技術分類(2026-2033 年)

  • 射頻消融術
  • 微波消融術
  • 冷凍消融術
  • 不可逆電穿孔
  • 雷射輔助熱消融
  • 其他消融技術

第5章 全球腫瘤消融市場:依治療方法分類(2026-2033 年)

  • 外科消融術
  • 腹腔鏡消融術
  • 經皮術

第6章 全球腫瘤消融市場:依應用領域分類(2026-2033年)

  • 腎癌
  • 肝癌
  • 乳癌
  • 肺癌
  • 攝護腺癌
  • 結腸癌
  • 其他癌症

第7章 全球腫瘤消融市場:按地區分類(2026-2033 年)

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第8章 競爭情勢

  • Medtronic
  • Boston Scientific Corporation
  • Angio Dynamics
  • Johnson&Johnson Services Inc.
  • Theraclion
  • EDAP TMS
  • HS Hospital Service SPA
  • IceCure Medical

第9章

  • 分析方法
  • 關於 Coherent Market Insights
簡介目錄
Product Code: CMI1270

Tumor Ablation Market is estimated to be valued at USD 1,755.7 Mn in 2026 and is expected to reach USD 3,741.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 11.5% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 1,755.7 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 11.50% 2033 Value Projection: USD 3,741.1 Mn

The efficiency of this new method in curing cancer based on two things the size of the tumor and its convenience to the probes. Generally, for cancers 3 cm or less and easily used percutaneously the focus is to totally kill the malignancy. The larger the cancer the more problematic it is to gain contest cancer fatality, hence early therapy is vital.

Market Dynamics

Continuous increase in geriatric population is rising the financial burden on the healthcare system. As per Population Reference Bureau, the count of people in the U.S. aged 65 and above is assessed to approximately double from 52 million in 2018 to 95 million by 2060. Such increase in elderly population will consequently lead in greater need for ablation devices for therapy of tumor, fueling the market

On contrary, for introduced tools sold in the U.S., FDA's Center for Devices and Radiological Health controls the framework and standards about production, labeling, packaging, and storage. To receive grants and permissions, the organizations require to comply with an exhaustive list of standards offered by official regulatory and keep complete documentation of the similar things.

Key features of the study

  • This report provides in-depth analysis of the global tumor ablation market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global tumor ablation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Major players in the global tumor ablation therapy market are Medtronic, Johnson & Johnson Services Inc., Boston Scientific Corporation, IceCure Medical, EDAP TMS, Theraclion, H.S. Hospital Service SPA and AngioDyna mics.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global tumor ablation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tumor ablation market

Global Tumor Ablation Market Segmentation

  • By Technology
    • Radiofrequency Ablation
    • Microwave Ablation
    • Cryo Ablation
    • Irreversible Electroporation
    • Laser Based Thermal Ablation
    • Other Ablation Technologies
  • By Treatment
    • Surgical Ablation
    • Laparoscopic Ablation
    • Percutaneous Ablation
  • By Application
    • Kidney Cancers
    • Liver Cancers
    • Breast Cancers
    • Lung Cancers
    • Prostate Cancers
    • Colorectal Cancers
    • Other Cancers
  • By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
  • Key Players
    • Medtronic
    • Johnson & Johnson Services Inc.
    • Boston Scientific Corporation
    • IceCure Medical
    • EDAP TMS
    • Theraclion
    • H.S. Hospital Service SPA
    • AngioDynamics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Technology
    • Market Snapshot, By Treatment
    • Market Snapshot, By Application
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising incidences of cancer
    • Complications linked to tumor ablation therapy
    • Rising perception regarding ablation process through conventional therapeutics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Tumor Ablation Market, By Technology, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033(%)
    • Y-o-Y Growth Analysis, 2026-2033
    • Segment Trends
  • Radiofrequency Ablation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Microwave Ablation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Cryo Ablation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Irreversible Electroporation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Laser Based Thermal Ablation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Other Ablation Technologies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global Tumor Ablation Market, By Treatment, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033(%)
    • Y-o-Y Growth Analysis, 2026-2033
    • Segment Trends
  • Surgical Ablation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Laparoscopic Ablation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Percutaneous Ablation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global Tumor Ablation Market, By Application, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033(%)
    • Y-o-Y Growth Analysis, 2026-2033
    • Segment Trends
  • Kidney Cancers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Liver Cancers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Breast Cancers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Lung Cancers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Prostate Cancers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Colorectal Cancers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Other Cancers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

7. Global Tumor Ablation Market, By Region, 2026-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026-2033(%)
    • Y-o-Y Growth Analysis, 2026-2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2026-2033, (USD Mn)
    • Market Size and Forecast and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2026-2033, (USD Mn)
    • Market Size and Forecast and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2026-2033, (USD Mn)
    • Market Size and Forecast and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2026-2033, (USD Mn)
    • Market Size and Forecast and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
  • Middle East &Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2026-2033, (USD Mn)
    • Market Size and Forecast and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)

8. Competitive Landscape

  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Angio Dynamics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson& Johnson Services Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Theraclion
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • EDAP TMS
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • H.S Hospital Service SPA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • IceCure Medical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

  • Research Methodology
  • About Us